Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29863955

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Jun 14
First author
Socinski MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Oct;15(10):593-594. doi: 10.1038/s41571-018-0070-7.
    note
    Source null
    related pmid
    29993034
    relationship
    Comment in
  2. citation
    N Engl J Med. 2018 Sep 20;379(12):1187. doi: 10.1056/NEJMc1809195.
    note
    Source null
    related pmid
    30260156
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 Sep 20;379(12):1187-8. doi: 10.1056/NEJMc1809195.
    note
    Source null
    related pmid
    30260157
    relationship
    Comment in
  4. citation
    J Thorac Dis. 2018 Sep;10(Suppl 26):S3155-S3159. doi: 10.21037/jtd.2018.07.92.
    note
    Source null
    related pmid
    30370103
    relationship
    Comment in
  5. citation
    J Thorac Dis. 2018 Sep;10(Suppl 26):S3241-S3243. doi: 10.21037/jtd.2018.08.82.
    note
    Source null
    related pmid
    30370125
    relationship
    Comment in
  6. citation
    Transl Cancer Res. 2019 Mar;8(Suppl 2):S103-S105. doi: 10.21037/tcr.2018.11.06.
    note
    Source null
    related pmid
    35117074
    relationship
    Comment in

Authors and identifiers

  1. name
    Socinski MA
    type
    Author
  2. name
    Jotte RM
    type
    Author
  3. name
    Cappuzzo F
    type
    Author
  4. name
    Orlandi F
    type
    Author
  5. name
    Stroyakovskiy D
    type
    Author
  6. name
    Nogami N
    type
    Author
  7. name
    Rodríguez-Abreu D
    type
    Author
  8. name
    Moro-Sibilot D
    type
    Author
  9. name
    Thomas CA
    type
    Author
  10. name
    Barlesi F
    type
    Author
  11. name
    Finley G
    type
    Author
  12. name
    Kelsch C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Socinski MA
    type
    Author
  2. name
    Jotte RM
    type
    Author
  3. name
    Cappuzzo F
    type
    Author
  4. name
    Orlandi F
    type
    Author
  5. name
    Stroyakovskiy D
    type
    Author
  6. name
    Nogami N
    type
    Author
  7. name
    Rodríguez-Abreu D
    type
    Author
  8. name
    Moro-Sibilot D
    type
    Author
  9. name
    Thomas CA
    type
    Author
  10. name
    Barlesi F
    type
    Author
  11. name
    Finley G
    type
    Author
  12. name
    Kelsch C
    type
    Author
bibliography ids
  1. nci-bib-84de8036d9936e2a77431f76
book metadata
content sha256
d4835d675cd034b7562d0ecfca1bc5dc5c61d141e770cbd9c7f72e8ac885afac
document type
citation
dois
  1. 10.1056/NEJMoa1716948
electronic publication date
display
2018 Jun 4
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29863955
immutable id
pubmed:29863955@d4835d675cd034b7562d0ecfca1bc5dc5c61d141e770cbd9c7f72e8ac885afac
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
24
name
The New England journal of medicine
nlm unique id
0255562
pages
2288-2301
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Oct;15(10):593-594. doi: 10.1038/s41571-018-0070-7.
    note
    Source null
    related pmid
    29993034
    relationship
    Comment in
  2. citation
    N Engl J Med. 2018 Sep 20;379(12):1187. doi: 10.1056/NEJMc1809195.
    note
    Source null
    related pmid
    30260156
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 Sep 20;379(12):1187-8. doi: 10.1056/NEJMc1809195.
    note
    Source null
    related pmid
    30260157
    relationship
    Comment in
  4. citation
    J Thorac Dis. 2018 Sep;10(Suppl 26):S3155-S3159. doi: 10.21037/jtd.2018.07.92.
    note
    Source null
    related pmid
    30370103
    relationship
    Comment in
  5. citation
    J Thorac Dis. 2018 Sep;10(Suppl 26):S3241-S3243. doi: 10.21037/jtd.2018.08.82.
    note
    Source null
    related pmid
    30370125
    relationship
    Comment in
  6. citation
    Transl Cancer Res. 2019 Mar;8(Suppl 2):S103-S105. doi: 10.21037/tcr.2018.11.06.
    note
    Source null
    related pmid
    35117074
    relationship
    Comment in
outcomes validated
false
pmid
29863955
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
60465a97054fc8ec2498d3e6cb8f1a7b755495d49148c6d9be5b5488f2892fa0
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Jun 14
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29863955/
title
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.

Preserved source evidence · Not medical advice